SCHEMBL3609852

SCHEMBL3609852

Ic1ccccc1Sc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB4A P04350 1/20 0.45
TUBB P07437 1/20 0.45
TUBA3C P0DPH7 1/20 0.45
TUBA1B P68363 1/20 0.45
TUBA4A P68366 1/20 0.45
TUBB4B P68371 1/20 0.45
TUBB3 Q13509 1/20 0.45
TUBB2A Q13885 1/20 0.45
TUBB8 Q3ZCM7 1/20 0.45
TUBA3E Q6PEY2 1/20 0.45
TUBA1A Q71U36 1/20 0.45
TUBA1C Q9BQE3 1/20 0.45
TUBB6 Q9BUF5 1/20 0.45
TUBB2B Q9BVA1 1/20 0.45
TUBB1 Q9H4B7 1/20 0.45
SIRT1 Q96EB6 1/20 0.45
MAPT P10636 4/20 0.44
TDP1 Q9NUW8 2/20 0.44
KDM4E B2RXH2 2/20 0.44
NSD2 O96028 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8006473 0.84 MEN1 (0.33) MAPTSMN1; SMN2MGLLKMT2AMEN1
SCHEMBL22063163 0.82 MAPT (0.47) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL23674203 0.82 SMN1; SMN2 (0.50) MAPTTDP1MAPK1SMN1; SMN2L3MBTL1
SCHEMBL29923079 0.82 SMN1; SMN2 (0.50) MAPTTDP1MAPK1SMN1; SMN2L3MBTL1
SCHEMBL20222310 0.82 CYP1A2 (0.46) MAPTTDP1KDM4EMAPK1HTR1A
SCHEMBL795029 0.81 SIRT1 (0.54) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL23729365 0.80 MAPT (0.48) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3897205 0.78 SIRT1 (0.52) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3900082 0.78 SIRT1 (0.52) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3897215 0.78 SIRT1 (0.52) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114981254-B Compound for organic electronic element, organic electronic element using the same, and electronic device having the same 德山新勒克斯有限公司 2025-06-24 CN disclosed
EP-3858945-B1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORP (US) 2023-11-29 EP disclosed
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed
CN-114981254-A Compound for organic electronic element, organic electronic element using the same, and electronic device having the organic electronic element 德山新勒克斯有限公司 2022-08-30 CN disclosed
CN-114057711-A Anthracene ketone spiro derivative and preparation method and application thereof 中国科学院理化技术研究所 2022-02-18 CN disclosed
WO-2021149998-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME 덕산네오룩스 주식회사 2021-07-29 WO disclosed
CN-101687781-B Compound for photoacid generator and use its anti-corrosion agent composition, pattern formation method CENTRAL GLASS CO.,LTD. (JP) 2015-08-12 CN disclosed
US-7732463-B2 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors H. LUNDBECK A/S (DK) 2010-06-08 US disclosed
CN-101687781-A Compound for photoacid generator, resist composition using the same, and pattern-forming method CENTRAL GLASS CO LTD 2010-03-31 CN disclosed
EP-1626720-B1 4-(2-PHENYLSULFANYL-PHENYL)-PIPERIDINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS LUNDBECK & CO AS H (DK) 2008-09-03 EP disclosed
US-20060100242-A1 such as 4-[2-(4-Chloro-phenylsulfanyl)-5-trifluoromethyl-phenyl]-piperidine, used as antidepressants and anxiolytic agents; treatment of panic and obsessive compulsive disorders H.LUNDBECK A/S (DK) 2006-05-11 US disclosed
EP-1626720-A1 4-(2-PHENYLSULFANYL-PHENYL)-PIPERIDINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS H. Lundbeck A/S (DK) 2006-02-22 EP disclosed
WO-2004087156-A1 4-(2-PHENYLSULFANYL-PHENYL)-PIPERIDINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS H. LUNDBECK A/S (DK) 2004-10-14 WO disclosed
EP-0236348-B1 CARBONYLATION PROCESS FOR THE PRODUCTION OF AROMATIC ACIDS EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1990-05-02 EP disclosed
EP-0236348-A1 CARBONYLATION PROCESS FOR THE PRODUCTION OF AROMATIC ACIDS. EASTMAN KODAK CO (US) 1987-09-16 EP disclosed
US-4649216-A Carbonylation process for the production of aromatic acids EASTMAN KODAK COMPANY (US) 1987-03-10 US disclosed
WO-1987000829-A1 CARBONYLATION PROCESS FOR THE PRODUCTION OF AROMATIC ACIDS EASTMAN KODAK COMPANY (US) 1987-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100242-A1 such as 4-[2-(4-Chloro-phenylsulfanyl)-5-trifluoromethyl-phenyl]-piperidine, used as antidepressants and anxiolytic agents; treatment of panic and obsessive compulsive disorders HTR4, HTR5A, TPH1 TUBB4A 1084/4885TUBB 1631/4885TUBA3C 1067/4885
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME ORAI2, OR10J3, OR51E2 TUBB4A 3989/4885TUBB 4476/4885TUBA3C 4490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.